Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study

C. R. Rowan, D. Keegan, K. Byrne, G. Cullen, H. E. Mulcahy, J. Sheridan, E. J. Ryan, A. de Vries, G. D'Haens, G. A. Doherty

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science